A U.S. Supreme Court challenge to an Eleventh Circuit ruling in pay-for-delay pacts in pharmaceutical cases is idling most of the pending litigation nationally.
Drug makers push for litigation freeze
Daily Business Review
October 29, 2012
This article requires premium access
This article requires premium access to Daily Business Review. Please sign in or subscribe to read the full text.